Squarepoint Ops LLC Harrow Health, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 14,724 shares of HROW stock, worth $516,517. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,724

Previous 20,000 26.38%

Holding current value

$516,517

Previous $417,000 58.51%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$20.85 - $46.47 $306,995 - $684,224	14,724 New	14,724 $661,000
Q1 2024 May 15, 2024	SELL	$9.3 - $13.23 $365,034 - $519,290	-39,251 Reduced 67.06%	19,281 $255,000
Q4 2023 Feb 14, 2024	BUY	$8.1 - $16.36 $474,109 - $957,583	58,532 New	58,532 $655,000
Q1 2023 May 15, 2023	BUY	$13.84 - $21.46 $339,315 - $526,134	24,517 New	24,517 $518,000
Q1 2021 May 17, 2021	SELL	$6.26 - $11.03 $95,064 - $167,501	-15,186 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.76 - $6.93 $72,285 - $105,238	15,186 New	15,186 $104,000
Q2 2020 Aug 14, 2020	SELL	$3.61 - $6.47 $123,952 - $222,153	-34,336 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$3.5 - $7.31 $285,474 - $596,232	-81,564 Reduced 70.37%	34,336 $131,000
Q4 2019 Feb 14, 2020	BUY	$4.6 - $7.88 $65,329 - $111,911	14,202 Added 13.96%	115,900 $902,000
Q3 2019 Nov 14, 2019	BUY	$4.89 - $8.0 $8,557 - $14,000	1,750 Added 1.75%	101,698 $572,000
Q2 2019 Aug 14, 2019	BUY	$4.2 - $8.7 $131,678 - $272,762	31,352 Added 45.71%	99,948 $870,000
Q1 2019 May 15, 2019	BUY	$4.75 - $7.1 $325,831 - $487,031	68,596 New	68,596 $342,000

Others Institutions Holding HROW

# of Institutions

177

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $950M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Harrow Health, Inc. Transaction History